Glucotrack (GCTK) Income from Continuing Operations (2010 - 2025)
Glucotrack (GCTK) recorded quarterly Income from Continuing Operations of 3487000.0 in Q4 2025, up 19.08% on a QoQ basis from 4309000.0 in Q3 2025, and up 9.52% year-over-year from 3183818.53 in Q4 2024.
Glucotrack (GCTK) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Glucotrack has disclosed Income from Continuing Operations across 15 years of filings, most recently posting 3487000.0 for Q4 2025.
- Quarterly Income from Continuing Operations rose 9.52% year-over-year to 3487000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 16090000.0 (down 10.57% YoY) and the FY2025 annual result came in at 16090000.0, down 10.61% from the prior year.
- Income from Continuing Operations rose to 3487000.0 in Q4 2025, from 4309000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 767000.0 in Q3 2021 and troughed at 4796000.0 in Q2 2025.
- A 5-year average of 2310950.0 and a median of 1864000.0 in 2021 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations advanced 14.43% — and 2024, when it tumbled 280.92%.
- Tracing GCTK's Income from Continuing Operations over 5 years: stood at 1504000.0 in 2021, then increased by 14.43% to 1287000.0 in 2022, then sank by 87.8% to 2417000.0 in 2023, then sank by 59.45% to 3854000.0 in 2024, then rose by 9.52% to 3487000.0 in 2025.
- Business Quant data shows GCTK's Income from Continuing Operations at 3487000.0 in Q4 2025, 4309000.0 in Q3 2025, and 4796000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Glucotrack | 4.26 | -7.38 Mn | - | -3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.49 Mn |
| Sep 30, 2025 | -4.31 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | -3.50 Mn |
| Dec 31, 2024 | -3.85 Mn |
| Sep 30, 2024 | -3.26 Mn |
| Jun 30, 2024 | -4.49 Mn |
| Mar 31, 2024 | -2.95 Mn |
| Dec 31, 2023 | -2.42 Mn |
| Sep 30, 2023 | -2.22 Mn |
| Jun 30, 2023 | -1.18 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -930,000.00 |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -1.50 Mn |
| Sep 30, 2021 | -767,000.00 |
| Jun 30, 2021 | -873,000.00 |
| Mar 31, 2021 | -896,000.00 |